![Ruben Rathnasingham](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ruben Rathnasingham is the founder of Stratagent Life Sciences, Inc. Prior to founding Stratagent, he worked as a Vice President-Development at Corium International, Inc. and as a Member at the University of Michigan.
Rathnasingham holds graduate and doctorate degrees from the Massachusetts Institute of Technology and a graduate degree from Imperial College London.
| Companies | Position | End |
|---|---|---|
Stratagent Life Sciences, Inc.
 Stratagent Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops non-invasive drug therapies | Founder | 2007-09-27 |
University of Michigan
 University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
| CORIUM INTERNATIONAL INC | Corporate Officer/Principal | 2010-03-17 |
Active
Inactive
Listed companies
Private companies
| Private companies | 5 |
|---|---|
Stratagent Life Sciences, Inc.
Stratagent Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops non-invasive drug therapies | Health Technology |
Imperial College London
 Imperial College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
University of Michigan
University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Corium International, Inc.
 Corium International, Inc. Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of novel neuroscience therapies | Health Technology |
Select your edition
All financial news and data tailored to specific country editions
